Researchers have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition. The treatment, which uses ...

The woolly mammoth has been extinct for thousands of years, but Colossal Biosciences is pursuing technology that could help ...

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

By editing the polymers of discarded plastics, chemists have found a way to generate new macromolecules with more valuable properties than those of the starting material. Upcycling may help remedy the ...

When rice is in its flowering and grain-filling stages, it is more sensitive to high nighttime temperatures than high daytime ...

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...

A Brandon scientist says the future of agricultural crop research in Canada will be focused on gene editing and trait study, ...

Applied DNA Sciences, Inc. (NASDAQ: APDN) disclosed in an 8-K filing to the U.S. Securities and Exchange Commission that they had employed a company presentation for potential investor interactions.

In BlueAllele Corp. v. Intellia Therapeutics, Inc., 2024 U.S. Dist. Lexis 222094 (D. Del. Dec. 9, 2024)1, the District of ...

A ruthenium catalyst facilitated the polymerization, or polymer addition. Industrial firms have used this catalyst to make ...

Simultaneous discoveries in art and science highlight humanity's shared creativity, problem-solving, and the ...